BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND BLM, MGC131620, 641, ENSG00000197299, MGC131618, RECQ2, RECQL2, RECQL3, MGC126616, BS AND Diagnosis
23 results:

  • 1. Germline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: a multicenter study in Taiwan.
    Cheng SM; Su YY; Chiang NJ; Wang CJ; Chao YJ; Huang CJ; Tsai HJ; Chen SH; Chang CY; Tsai CR; Li YJ; Yen CJ; Chuang SC; Chang JS; Shan YS; Hwang DY; Chen LT
    J Biomed Sci; 2024 Feb; 31(1):21. PubMed ID: 38350919
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Beta-blocker use and survival after pancreatic cancer surgery: A nationwide population-based cohort study.
    Kirkegård J; Cronin-Fenton D; Lund A; Mortensen FV
    Pharmacoepidemiol Drug Saf; 2024 Jan; 33(1):e5726. PubMed ID: 37946571
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Comparison of characteristics and outcomes of young-onset versus average onset pancreatico-biliary adenocarcinoma.
    Jayakrishnan T; Nair KG; Kamath SD; Wei W; Estfan BN; Krishnamurthi SS; Khorana AA
    Cancer Med; 2023 Mar; 12(6):7327-7338. PubMed ID: 36621839
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Comparative Performance of Endoscopic Ultrasound-Based Techniques in Patients With pancreatic Cystic Lesions: A Network Meta-Analysis.
    Li SY; Wang ZJ; Pan CY; Wu C; Li ZS; Jin ZD; Wang KX
    Am J Gastroenterol; 2023 Feb; 118(2):243-255. PubMed ID: 36563321
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Factors Affecting the Learning Curve in the Endoscopic Ultrasound-Guided Sampling of Solid pancreatic Lesions: A Prospective Study.
    Razpotnik M; Bota S; Kutilek M; Essler G; Urak C; Prosenz J; Weber-Eibel J; Maieron A; Peck-Radosavljevic M
    Gut Liver; 2023 Mar; 17(2):308-317. PubMed ID: 36424720
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Prognostic impact of conversion hepatectomy for initially unresectable colorectal liver metastasis.
    Takamizawa Y; Inoue M; Moritani K; Tsukamoto S; Esaki M; Shimada K; Kanemitsu Y
    Langenbecks Arch Surg; 2022 Nov; 407(7):2893-2903. PubMed ID: 36068379
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Intraductal tubulopapillary neoplasms of the bile ducts: identity, clinicopathologic characteristics, and differential diagnosis of a distinct entity among intraductal tumors.
    Pehlivanoglu B; Adsay V
    Hum Pathol; 2023 Feb; 132():12-19. PubMed ID: 35934108
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. In-Hospital Outcomes and Recurrence of Acute Ischemic Stroke in Patients With Solid Organ Malignancy.
    Garg A; Chopra S; Starr M; Rocha M; Dawod J; Leira E; Shaban A
    Neurology; 2022 Jul; 99(4):e393-e401. PubMed ID: 35487697
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The impact of the multidisciplinary tumor board (MDTB) on the management of pancreatic diseases in a tertiary referral center.
    Quero G; Salvatore L; Fiorillo C; Bagalà C; Menghi R; Maria B; Cina C; Laterza V; Di Stefano B; Maratta MG; Ribelli M; Galiandro F; Mattiucci GC; Brizi MG; Genco E; D'Aversa F; Zileri L; Attili F; Larghi A; Perri V; Inzani F; Gasbarrini A; Valentini V; Costamagna G; Manfredi R; Tortora G; Alfieri S
    ESMO Open; 2021 Feb; 6(1):100010. PubMed ID: 33399076
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Structured Reporting of Solid and Cystic pancreatic Lesions in CT and MRI: Consensus-Based Structured Report Templates of the German Society of Radiology (DRG).
    Persigehl T; Baumhauer M; Baeßler B; Beyer LP; Bludau M; Bruns C; Bunck AC; Germer CT; Grenacher L; Hackländer T; Haneder S; Heinrich S; Heusch P; Hoffmann M; Juchems MS; Kröger JR; Kotter E; Layer G; Maintz D; Menke J; Palmowski M; Pantelis D; Pinto Dos Santos D; Popp FC; Schäfer N; Schlemmer HP; Schreyer AG; Siedek F; Stippel D; Völker M; Waldschmidt DT; Weber TF; von Winterfeld M; Wybranski C; Zander T; Wessling J
    Rofo; 2020 Jul; 192(7):641-656. PubMed ID: 32615626
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Cholangiocarcinoma Following Bariatric Surgery: a Prospective Follow-Up Single-Center Audit.
    Beghdadi N; Lim C; Aron-Wisnewsky J; Torcivia A; Goumard C; Turco C; Vaillant JC; Siksik JM; Oppert JM; Scatton O; Genser L
    Obes Surg; 2020 Sep; 30(9):3590-3594. PubMed ID: 32385663
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial.
    Pishvaian MJ; Blais EM; Brody JR; Lyons E; DeArbeloa P; Hendifar A; Mikhail S; Chung V; Sahai V; Sohal DPS; Bellakbira S; Thach D; Rahib L; Madhavan S; Matrisian LM; Petricoin EF
    Lancet Oncol; 2020 Apr; 21(4):508-518. PubMed ID: 32135080
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Preparation of Dual-Template Epitope Imprinted Polymers for Targeted Fluorescence Imaging and Targeted Drug Delivery to pancreatic cancer BxPC-3 Cells.
    Jia C; Zhang M; Zhang Y; Ma ZB; Xiao NN; He XW; Li WY; Zhang YK
    ACS Appl Mater Interfaces; 2019 Sep; 11(35):32431-32440. PubMed ID: 31393695
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Diagnostic performance of contrast-enhanced ultrasound for pancreatic neoplasms: A systematic review and meta-analysis.
    Li XZ; Song J; Sun ZX; Yang YY; Wang H
    Dig Liver Dis; 2018 Feb; 50(2):132-138. PubMed ID: 29162410
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Decision-Making for the Management of Cystic Lesions of the Pancreas: How Satisfied Are Patients with Surgery?
    Puri PM; Watkins AA; Kent TS; Maggino L; Jeganathan JG; Callery MP; Drebin JA; Vollmer CM
    J Gastrointest Surg; 2018 Jan; 22(1):88-97. PubMed ID: 28875275
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Biliary fistula after liver resection: central role of intraoperative perihepatic drain.
    Barabino M; Gatti A; Santambrogio R; Centonze L; Virdis M; Angiolini MR; Luigiano C; Opocher E
    Minerva Chir; 2016 Dec; 71(6):353-359. PubMed ID: 27787479
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The risk for developing cancer in Israeli ATM, blm, and FANCC heterozygous mutation carriers.
    Laitman Y; Boker-Keinan L; Berkenstadt M; Liphsitz I; Weissglas-Volkov D; Ries-Levavi L; Sarouk I; Pras E; Friedman E
    Cancer Genet; 2016 Mar; 209(3):70-4. PubMed ID: 26778106
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Microarray expression profile analysis of long non-coding RNAs in pancreatic ductal adenocarcinoma.
    Zhou Y; Gong B; Jiang ZL; Zhong S; Liu XC; Dong K; Wu HS; Yang HJ; Zhu SK
    Int J Oncol; 2016 Feb; 48(2):670-80. PubMed ID: 26676849
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Diabetes, smoking, alcohol use, and family history of cancer as risk factors for pancreatic neuroendocrine tumors: a systematic review and meta-analysis.
    Haugvik SP; Hedenström P; Korsæth E; Valente R; Hayes A; Siuka D; Maisonneuve P; Gladhaug IP; Lindkvist B; Capurso G
    Neuroendocrinology; 2015; 101(2):133-42. PubMed ID: 25613442
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Ki-67 cytological index can distinguish well-differentiated from poorly differentiated pancreatic neuroendocrine tumors: a comparative cytohistological study of 53 cases.
    Carlinfante G; Baccarini P; Berretti D; Cassetti T; Cavina M; Conigliaro R; De Pellegrin A; Di Tommaso L; Fabbri C; Fornelli A; Frasoldati A; Gardini G; Losi L; Maccio L; Manta R; Pagano N; Sassatelli R; Serra S; Camellini L
    Virchows Arch; 2014 Jul; 465(1):49-55. PubMed ID: 24807732
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.